Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
McKinsey
Farmers Insurance
Argus Health
US Army
Deloitte
Cipla
Colorcon

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011525

« Back to Dashboard

NDA 011525 describes IC-GREEN, which is a drug marketed by Akorn and is included in one NDA. It is available from three suppliers. Additional details are available on the IC-GREEN profile page.

The generic ingredient in IC-GREEN is indocyanine green. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.
Summary for 011525
Tradename:IC-GREEN
Applicant:Akorn
Ingredient:indocyanine green
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 011525
Suppliers and Packaging for NDA: 011525
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IC-GREEN indocyanine green INJECTABLE;INJECTION 011525 NDA Akorn, Inc. 17478-701 17478-701-02 1 KIT in 1 CARTON (17478-701-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE * 10 mL in 1 AMPULE
IC-GREEN indocyanine green INJECTABLE;INJECTION 011525 NDA Novadaq Technologies Inc. 66259-701 66259-701-25 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (66259-701-25)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength25MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Harvard Business School
Moodys
Merck
Dow
Boehringer Ingelheim
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.